|
|
Overview
Highlights
News
Chart
Contacts
|
|
|
|
|
|
|
|
|
| | "Dialysis
Corporation of America partners with physicians and hospitals to build and
operate dialysis centers focused on delivering consistently high quality
care to patients with failed kidney function."
|
| |
|
| |
|
|
|
| Approximate
Financial Snapshot as of 1/7/08 |
|
| Shares
Outstanding |
9.6M |
| 52
Wk Hi/Lo |
14.16/
7.70
|
| Market
Cap |
$77.3M |
| Recent
Price |
$8.05 |
|
|
|
|
|
|
1/7/08
Dialysis
Corporation of America (DCAI)

Website:
www.dialysiscorporation.com
A
synergistic approach to sound medical and business practices.
Overview
Dialysis Corporation of America
(Nasdaq: DCAI)
through its subsidiaries, engages in the
development and operation of outpatient kidney dialysis centers in the
United States and internationally. It offers outpatient hemodialysis
services, home dialysis services, inpatient dialysis services, and ancillary
services associated with dialysis treatments.
The company provides dialysis
and ancillary services to patients suffering from chronic kidney failure,
also known as end-stage renal disease. It also offers acute inpatient
dialysis treatments in hospitals, homecare services, and dialysis center
management services.
DCAI owns 35 free standing kidney
hemodialysis centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland,
Virginia and South Carolina. In addition, Dialysis Corporation distributes medical
products, primarily disposables and diabetic supplies to hospitals, blood
banks, laboratories, and retail pharmacies, as well as offers a line of
blood lancets used to draw blood for testing.
DCAI partners with physicians and hospitals
providing the needed balance to consistently deliver high quality care to
patients with failed kidney function.
To assist with effective and efficient
operations management, DCAI provides clinical, regulatory and technical
services, billing and reimbursement, general accounting, human resources,
information systems, purchasing and marketing. Optimal size and flexibility
are advantages DCAI brings to every strategic business relationship.
DCAI
Investor Highlights
- Announced the acquisition
of a majority interest in a dialysis center Georgia. The center has a
total of 16 treatment stations, and a patient census of approximately 77
patients.
- Owns 35 free standing kidney hemodialysis
centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland, Virginia
and South Carolina.
- Operating revenues for the third quarter
were $19.1 M compared to $16.5 M for the same period last year, a 16%
increase.
- Net income for the third quarter was
$927,000 or $.10 per share compared to $814,000 or $.09 per share for
the same period last year.
- Operating revenues for the first nine
months of 2007 were $54.5 M compared to $44.2 M for the same period last
year.
- Net income for the first nine months of
2007 was $2.0 M or $.22 per share compared to $1.9 M or $.20 per share
for the same period last year.
Recent
News and Press Releases
Dialysis
Corporation of America Announces Opening of New Dialysis Center in Ohio
Dialysis
Corporation of America Announces Acquisition of Georgia Dialysis Center
Dialysis
Corporation of America Reports Third Quarter 2007 Results
For the latest Quote
and News on DCAI Click
Here.
Three
Month Chart
Contacts
Dialysis Corp. of America
1302 Concourse Drive
Suite 204
Linthicum, MD 21090
Phone: 410-694-0500
Fax: 410-694-0596
SEC Filings
DCAI filings with the SEC can be found here.
All Fillings are current and the Company is fully reporting.
Disclaimer
SmallCapReview.com
feature stock reports are intended to be stock ideas, NOT recommendations.
Please do your own research before investing. It is crucial that you at
least look at current SEC filings and read the latest press releases.
For continuing coverage of DCAI, please sign up for our free newsletter.
Information contained in this report was extracted from current documents
filed with the SEC, the company web site and other publicly available
sources deemed reliable. For more information see our disclaimer section, a
link of which can be found on our web site. This document contains
forward-looking statements, particularly as related to the business plans of
the Company, within the meaning of Section 27A of the Securities Act of 1933
and Sections 21E of the Securities Exchange Act of 1934, and are subject to
the safe harbor created by these sections. Actual results may differ
materially from the Company's expectations and estimates. The information
provided in this report is not intended for distribution to, or use by, any
person or entity in any jurisdiction or country where such distribution or
use would be contrary to law or regulation or which would subject us to any
registration requirement within such jurisdiction or country.
Copyright
SmallCapReview.com. All rights reserved. SmallCapReview.com is not a
Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out
to be. All materials presented on our web site and individual reports
released to the public through this web site, e-mail or any other means of
transmission are not to be regarded as investment advice and are only
for informative purposes. Before making a purchase or sale of any securities featured
on our web site or mentioned in our reports, we strongly encourage and
recommend consultation with a registered securities representative.
This is not to be construed as a solicitation or recommendation to buy or
sell securities. As with any stock, companies we select to profile involve a
degree of investment risk and volatility. Particularly Small-Caps and OTC-BB
stocks. All investors are cautioned that they may lose all or a portion of
their investment if they decide to make a purchase in any of our profiled
companies. Past performance of our profiled stocks is not indicative of
future results. The accuracy or completeness of the information on our web
site or within our reports is only as reliable as the sources they were
obtained from. The profile and opinions expressed herein are expressed
as of the date the profile is posted on site and are subject to change
without notice. No investor should assume that reliance on the views,
opinions or recommendations contained herein will produce profitable
results. SmallCapReview.com may hold
positions in securities mentioned herein, and may make purchases or sales in
such securities featured on our web site or within our reports. In order to
be in full compliance with the Securities Act of 1933, Section 17(b),
SmallCapReview.com will disclose in it's disclaimer, what, if any
compensation was received for our efforts in researching, presenting
and disseminating this information to our subscriber database and featuring
the report on the SmallCapReview.com web site. SmallCapReview.com
has not been compensated for its efforts in presenting the Dialysis
Corporation of America profile on its website and distributing it to its
database of subscribers. SmallCapReview.com
may decide to purchase or sell shares on a voluntary basis in the open
market before, during or after the profiling period of this report.
Information presented on our web site and within our reports contain
"forward looking statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934. Any statements that express or
involve discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact and may be "forward
looking statements." Forward looking statements are based on
expectations, estimates and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through the use
of words such as “expects’”, “will,” “anticipates,”
“estimates, “believes,” or that by statements indicating certain
actions “may,” “could,” or “might” occur.
THE
READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE
INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP
SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
We
encourage our readers to invest carefully and read the investor information
available at the web sites of the Securities and Exchange Commission (SEC)
at: http://www.sec.gov
and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com
. Readers can review all public filings by companies at the SEC's EDGAR
page. The NASD has published information on how to invest carefully at its
web site.
|